4 hours Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Consensus Rating of “Hold” from Brokerages MarketBeat
Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) have been given an average rating of “Hold” by the eight analysts that are currently covering the firm, Marketbeat reports. Six research analysts have rated the stock with a hold r…
Nasdaq 100 · Pharmaceuticals · Science